Edition:
United States

Biotechnology & Medical Research

Page 1

Doxa signs distribution agreement in Italy

Tuesday, 26 Jul 2016 02:50am EDT

Doxa AB :Signs distribution agreement with Revello regarding sales of Ceramir Crown & Bridge in Italy.

Peptidream announces license of PDPS technology to Genentech Inc

Wednesday, 20 Jul 2016 03:26am EDT

PeptiDream Inc <4587.T>: Says it entered into a technology license agreement with U.S.-based company Genentech Inc to nonexclusively license PeptiDream’s proprietary Peptide Discovery Platform System (PDPS) technology . Says PeptiDream will receive an undisclosed upfront payment, annual technology access payments, and is eligible to receive payments based on achievement of certain redetermined development milestones .Says PeptiDream is eligible to receive royalties on sales of certain products that arise from use of the PDPS technology.

Doxa signs new distribution agreement for in Netherlands

Tuesday, 12 Jul 2016 02:34am EDT

Doxa AB :Signs new distribution agreement for Ceramir Crown & Bridge in Holland.

Biolife Solutions says entered into 10-year supply agreement with Kite Pharma

Monday, 11 Jul 2016 06:30am EDT

Biolife Solutions Inc : Biolife solutions executes 10 year supply agreement with kite pharma for Cryostor use in CAR T cell therapies . Agreement provides for Kite's supply of Biolife's Cryostor clinical grade freeze media for cells and tissues .Says entered into a ten year supply agreement with Kite Pharma.

Sprint Bioscience signs licence agreement for PIP4K2-program

Thursday, 7 Jul 2016 02:30am EDT

Sprint Bioscience AB : Signs licence agreement for PIP4K2-program with Petra Pharma Corporation .Says can receive up to about $240 million in milestone payment including an upfront payment of $3 million.

Pangen Biotech signs contract worth 600 mln won

Wednesday, 29 Jun 2016 02:46am EDT

Pangen Biotech <222110.KQ> Inc.: Says it signs contract with SAM CHUN DANG PHARM CO. LTD, to provide protein .Contract amount of 600 million won.

MDxHealth contracts with Priority Health for coverage of ConfirmMDx

Thursday, 23 Jun 2016 01:00am EDT

MDxHealth SA :Contracts with Priority Health, a Michigan-based health plan with nearly 720,000 members, for coverage of ConfirmMDx for Prostate Cancer testing for its Commercial and Medicare Advantage members.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.